PSK1 COST-EFFECTIVENESS ANALYSIS OF AMEVIVE TM (ALEFACEPT) IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS
May 1, 2005, 00:00
10.1016/S1098-3015(10)62865-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)62865-3/fulltext
Title :
PSK1 COST-EFFECTIVENESS ANALYSIS OF AMEVIVE TM (ALEFACEPT) IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62865-3&doi=10.1016/S1098-3015(10)62865-3
First page :
Section Title :
Open access? :
No
Section Order :
302